We contribute to establishing a robust and competitive Cancer Cell Therapy pipeline at Astellas.

  • Modality
  • Project Code
  • Mechanism
  • Discovery
  • Preclinical
  • Phase 1
  • Partner
Cell Therapy
Not disclosed
CD20 convertibleCAR-T
Not disclosed

Accurate as of March 2023

Programs listed above include programs of other Astellas affiliates [and those partnered with third parties].

Please see our overall Astellas Immuno-Oncology pipeline.